XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of fair value measurement

The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy:

 

    Fair Value Measurement at March 31, 2021  
    Total     Level 1     Level 2     Level 3  
Investments in convertible and term
promissory notes of AVLP and Ault &
Company – related parties
  $ 13,467,783     $     $     $ 13,467,783  
Investments in common stock and derivative
instruments of AVLP – a related party
    10,335,348       819,324             9,516,024  
Investment in common stock and warrants of
Alzamend – a related party
    4,487,091                   4,487,091  
Investments in marketable equity securities     18,153,863       18,153,863              
Securities purchased under agreement to resell     33,647,059       33,647,059                  
Investments in debt and equity securities     2,320,539             506,574       1,813,965  
Total Investments   $ 82,411,683     $ 52,620,246     $ 506,574     $ 29,284,863  

 

    Fair Value Measurement at December 31, 2020  
    Total     Level 1     Level 2     Level 3  
Investments in convertible promissory notes
and advances of AVLP and Alzamend – related
parties
  $ 10,668,470     $     $     $ 10,668,470  
Investments in common stock and derivative
instruments of AVLP – a related party
    5,486,140       499,588             4,986,552  
Investment in common stock and warrants of
Alzamend – a related party
    653,251                   653,251  
Investments in marketable equity securities     2,562,983       2,562,983              
Investments in debt and equity securities     261,767                   261,767  
Total Investments   $ 19,632,611     $ 3,062,571     $     $ 16,570,040  
Schedule of summarizes the changes in investments

The following table summarizes the changes in investments in debt and equity securities measured and carried at fair value on a recurring basis with the use of significant unobservable inputs (Level 3) for the three months ended March 31, 2021:

 

    Investments in  
    debt and equity  
    securities  
Balance at January 1, 2021   $ 261,767  
Investment in convertible promissory notes     500,000  
Investment in warrants     1,000,000  
Change in fair value of warrants     57,560  
Accretion of discount     52,198  
Balance at March 31, 2021   $ 2,320,539